Engineering CRISPR/Cas-based nanosystems for therapeutics, diagnosis and bioimaging
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Tianjin City
National Key Research and Development Program of China
Publisher
Elsevier BV
Subject
General Chemistry
Reference146 articles.
1. The promise and challenge of therapeutic genome editing
2. The delivery challenge: fulfilling the promise of therapeutic genome editing
3. The new frontier of genome engineering with CRISPR-Cas9
4. Therapeutic genome editing: prospects and challenges
5. Enabling functional genomics with genome engineering
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CRISPR/Pepper‐tDeg: A Live Imaging System Enables Non‐Repetitive Genomic Locus Analysis with One Single‐Guide RNA;Advanced Science;2024-06-26
2. CRISPR/Cas12a-Powered Amplification-Free RNA Diagnostics by Integrating T7 Exonuclease-Assisted Target Recycling and Split G-Quadruplex Catalytic Signal Output;Analytical Chemistry;2024-06-11
3. Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment;MedComm – Biomaterials and Applications;2024-01-14
4. CRISPR-Cas12a-enhanced mass spectrometric DNA nanomachine for HPV-16 detection in human serum;Chemical Communications;2024
5. Enzyme-Free Crispr/Cas12a Microrna Assay by Amplified Single Particle Analysis;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3